CS
MRK icon

Capital Square’s Merck MRK Stock Holding History

Capital Square’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.48M Buy
13,216
+118
+0.9% +$13.6K 0.68% 39
2025
Q4 		$1.38M Sell
13,098
-40
-0.3% -$3.75K 0.7% 40
2025
Q3 		$1.1M Sell
13,138
-461
-3% -$38K 0.56% 52
2025
Q2 		$1.13M Buy
13,599
+1,905
+16% +$151K 0.6% 50
2025
Q1 		$1.05M Buy
11,694
+513
+5% +$47.9K 0.62% 55
2024
Q4 		$1.07M Buy
11,181
+310
+3% +$32K 0.61% 51
2024
Q3 		$1.23M Buy
10,871
+443
+4% +$52.6K 0.75% 38
2024
Q2 		$1.31M Sell
10,428
-252
-2% -$32.5K 0.85% 38
2024
Q1 		$1.41M Buy
10,680
+1,132
+12% +$140K 0.99% 31
2023
Q4 		$1.04M Buy
9,548
+7
+0.1% +$727 1.18% 31
2023
Q3 		$973K Sell
9,541
-48
-0.5% -$5.17K 1.31% 29
2023
Q2 		$1.11M Buy
9,589
+69
+0.7% +$7.83K 1.02% 34
2023
Q1 		$1.07M Sell
9,520
-116
-1% -$12.5K 0.99% 33
2022
Q4 		$1.07M Buy
9,636
+44
+0.5% +$4.5K 0.97% 32
2022
Q3 		$826K Sell
9,592
-46
-0.5% -$4.11K 0.75% 43
2022
Q2 		$878K Sell
9,638
-146
-1% -$12.9K 0.73% 45
2022
Q1 		$802K Sell
9,784
-51
-0.5% -$4.02K 0.57% 58
2021
Q4 		$775K Sell
9,835
-504
-5% -$40.1K 0.54% 67
2021
Q3 		$841K Sell
10,339
-257
-2% -$19.5K 0.6% 58
2021
Q2 		$809K Sell
10,596
-524
-5% -$39K 0.6% 58
2021
Q1 		$809K Buy
11,120
+3,589
+48% +$265K 0.6% 55
2020
Q4 		$587K Sell
7,531
-40
-0.5% -$3.06K 0.49% 64
2020
Q3 		$599K Buy
7,571
+124
+2% +$9.71K 0.62% 56
2020
Q2 		$549K Sell
7,447
-44
-0.6% -$3.31K 0.59% 60
2020
Q1 		$550K Buy
7,491
+17
+0.2% +$1.34K 0.64% 44
2019
Q4 		$648K Buy
+7,474
New +$614K 0.62% 46

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Square's MRK Position: Q1 2026 in Review

Capital Square increased its Merck (MRK) stake by 0.9% in Q1 2026, buying an estimated $13.6K and bringing the position to 13,216 shares worth $1.48M. The position accounts for 0.68% of the portfolio, ranked #39.

Capital Square first reported a position in MRK in Q4 2019 and has held it in 26 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Capital Square held 13,216 shares of Merck worth $1.48M as of Q1 2026.
  • Capital Square bought 118 Merck shares in Q1 2026, an estimated $13.6K.
  • Merck made up 0.68% of Capital Square's portfolio in Q1 2026, its #39 holding.
  • Capital Square first reported a position in Merck in Q4 2019 and has held it in 26 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Capital Square's 13F filing for Q1 2026, filed 11 May 2026.